期刊文献+

芹菜素囊泡的体内药动学和组织分布研究 被引量:3

Pharmacokinetics and Tissue Distribution of Apigenin Niosomes
原文传递
导出
摘要 目的使用非离子表面活性剂制备芹菜素囊泡,并对其进行大鼠体内药动学和小鼠体内组织分布的研究。方法采用乙醇注入法制备芹菜素囊泡,尾静脉注射芹菜素囊泡和自制芹菜素溶液,利用高效液相色谱法检测血浆和各组织中的芹菜素浓度,利用统计学方法计算芹菜素在大鼠体内的药动学参数及小鼠的组织分布参数。结果芹菜素囊泡包封率为(69.48±2.5)%,粒径为(148±5.03)nm。经尾静脉给予剂量为2mg·kg-1的芹菜素注射液和芹菜素囊泡注射液,体内药动结果显示,与注射液组相比,芹菜素囊泡组t1/2延长了2.02倍,AUC0-∞增加了1.85倍,MRT0-∞增加了2.16倍,组织分布结果显示,芹菜素囊泡在肝、肺、脑部AUQ(are under the amount of drug vs time curve,Q=C×V)显著增加,在心脏、肾脏AUQ减小。结论芹菜素囊泡明显延长了芹菜素在体内的循环时间,降低了药物在心、肾的蓄积,使得为临床提供安全有效的芹菜素制剂成为可能。 OBJECTIVE To study the preparation of apigenin niosomes and their pharmacokinetics in rats and tissue distribution in mice. METHODS Apigenin niosomes was prepared by ethanol injection method. The pharmacokinetics and tissue distribution of apigenin niosomes and apigenin solution were carried out in Wistar rats and KM mice by caudal vein injection, respectively. RESULTS The entrapment efficiency of the niosomes was (69.48±2.5)%, the average particle size was (148±5.03)nm.Compared with apigenin injection, the circulation time of apigenin niosomes in plasma was longer. The t1/2 was increased by 2.02 fold , the AUC0-∞ was increased by 1.85 fold and MRT0-∞ was increased by 2.16 fold. The AUCs0-∞ of liver, lung and brain were much bigger, while less in heart and kidney. CONCLUSION Apigenin niosomes can prolong the circulation in vivo, and reduce the accumulation in heart and kidney, which can improve curative effects and reduce toxicity.
出处 《中国药学杂志》 CAS CSCD 北大核心 2009年第13期1009-1013,共5页 Chinese Pharmaceutical Journal
关键词 芹菜素 囊泡 体内药动 组织分布 非离子表面活性剂 apigenin niosomes pharmacokinetics tissue dirtubution nonionic surfactant
  • 相关文献

参考文献10

  • 1Gupta PK,Hung CT.Quantitative evaluation of targeted drug delivery systems[].International Journal of Pharmaceutics.1989
  • 2Chen D,Daniel KG,Chen MS,et al.Dietary flavonoids as proteasome inhibitors and apoptosis inducers in human leukemia cells[].Biochemical Pharmacology.2005
  • 3KHANTH,,SULTANA S.Apigenin induces apoptosis in Hep G2 cells:possible role of TNF-αand IFN-γ[].Toxicology.2006
  • 4J.Allen Zhang,Gopal Anyarambhatla1,Lan Ma,et al.Developmentand characterization of a novel Cremophor EL free liposome-basedpaclitaxel(LEP-ETU)formulation[].European Journal of Pharma-ceutics and Biopharmaceutics.2005
  • 5Wang,S,Deng,Y,Xu,H.Synthesis of a novel galactosylated lipid and its application to the hepatocyte-selective targeting of liposomal oxorubicin[].European Journal of Pharmaceutics and Biopharmaceutics.2006
  • 6ArunothayanunP,Bernard MS,Craig DQ.The effect of processing variables on the physical characteristics of non-ionic surfactant vesicles (niosomes) formed from a hexadecyl diglycerol ether[].International Journal of Pharmaceutics.2000
  • 7A. Manosroi,P. Wongtrakul,J. Manosroi,H. Sakai,F. Sugawara,M. Yuasa,M. Abe.Characterization of vesicles prepared with various non ionic surfactants mixed with cholesterol[].Colloids Surf B Biointerfaces.2003
  • 8Maria Manconi,Chiara Sinico,Donatella Valenti,et al.Niosomes as carriers for tretinoin. I. Preparation and properties[].International Journal of Pharmaceutics.2002
  • 9S.P. Vyas R.P. Singh,Sanyog Jain,Vivek Mishra,Sunil Mahor,Paramjit Singh,P.N. Gupta,A. Rawat and P. Dubey.Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B[].International Journal of Pharmaceutics.
  • 10YOSHIOKAT,STENBERG B,JLORENCE AT.Prepa-ration and properties of vesicles(niosomes)of sorbitanmonoesters(span20,40,60 and 80)and a sorbitan tri-ester(span 85)[].International Journal of Pharmaceutics.1994

同被引文献62

  • 1肖衍宇,平其能.冰片-β-环糊精包合物对磷酸川芎嗪在小鼠血浆及脑组织分布的影响[J].中国药科大学学报,2009,40(5):412-415. 被引量:8
  • 2孙斌,瞿伟菁,张晓玲.芹菜素的药理作用研究进展[J].中药材,2004,27(7):531-534. 被引量:68
  • 3廉洁,王伯初.药物磷脂复合物工艺评价标准及应用研究进展[J].生物技术通讯,2006,17(5):830-833. 被引量:24
  • 4YangHL TianH LiPB.Biological activity of naringin and naringenin .中药材,2007,30:752-754.
  • 5YOSHIE M, YUSUKE T, MAKOTO K, et al. Site of drug absorp- tion after oral administration : Assessment of membrane permeabili- ty and luminal concentration of drugs in each segment of gastroin- testinal tract[ J]. Eur J Pharm Sci, 2006,29(34) :240-250.
  • 6SANIEEV S, SAN1AV G. Apigenin: A promising molecule for cancer prevention [ J ]. Pharm Res, 2010, 27 (6) :962-978.
  • 7SCHMIEDLIN-REN P, THUMMEL K E, FISHER I M, et al. Ex- pression of enzymatically active CYP3A4 by Caco-2 ceils grown on extracellular matrix-coated permeable supports in the presence of 1 a, 25-dihydroxyvitamin D3 [ J]. Mol Pharmacol, 1997, 51 (5) : 741-745.
  • 8Anisur Rahman Khuda-Bukhsh.Current trends in high dilution research with particular reference to gene regulatory hypothesis [J].Food and Chemical Toxicology, 2014,57 ( 1 ):3-17.
  • 9Zhai Y, Guo S, Liu C, et al.Preparation and in vitro evaluation of apigenin-loaded polymeric micelles[J]. Colloids and Surfaces A: Physicochemical and Engineering Aspects,2013,429 ( 10 ): 24-30.
  • 10侯君,周世文.固体脂质纳米粒研究新进展[J].解放军药学学报,2008,24(3):239-242. 被引量:7

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部